Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CYP1B1 contributors: mct - updated : 15-10-2024
HGNC name cytochrome P450, family 1, subfamily B, polypeptide 1
HGNC id 2597
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Cardiovascularheart   lowly
Digestiveintestinelarge intestinecolon highly
 liver   highly Homo sapiens
Lymphoid/Immunespleen   highly
 thymus   highly
Nervousbrain   lowly Homo sapiens
Reproductivefemale systemplacenta  lowly
 female systemovary  highly
 male systemprostate  highly
 male systemseminal vesicles  lowly
Respiratorylung   moderately
Urinarykidney   highly
Visualeyeanterior segment   
 eyeuvea   
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Muscularstriatum  lowly
cells
SystemCellPubmedSpeciesStageRna symbol
Blood/Hematopoieticleukocyte
Digestivehepatocyte Homo sapiens
Nervousastrocyte Homo sapiens
cell lineage expressed in human nonpigmented ciliary epithelial cell line
cell lines NHEK
fluid/secretion
at STAGE
physiological period embryo, fetal
Text eye, trabecular meshwork, fetal thymus
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
conjugated HemoP
mono polymer monomer
HOMOLOGY
interspecies ortholog to Cyp1b1, Mus musculus
ortholog to Cyp1b1, Rattus norvegicus
ortholog to cyp1b1, Danio rerio
Homologene
FAMILY
  • cytochrome P450 family
  • CATEGORY enzyme , transport
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,organelle,mitochondria,inner
    intracellular,cytoplasm,organelle,membrane
    intracellular,cytoplasm,organelle,endoplasmic reticulum
    intracellular,cytoplasm,cytosolic,microsome
    basic FUNCTION
  • cytochrome P450, possibly involved in the metabolism of substances active in the eye growth and differentiation
  • in liver microsomes involved in an NADPH-dependent electron transport pathway
  • playing a role in 4-hydroxylation of 17-beta-estradiol
  • inhibiting Na+,K+ ATPase in the cornea
  • may be an important source of retinoic acid
  • during embryonic and early postnatal development
  • monooxygenase, acting to form or degrade some endobiotic compound that is necessary for proper development of the filtering structures
  • involved in many metabolic processes including androgen metabolism
  • potential role of CYP1B1 in eye development
  • important in regulating endogenous metabolic pathways, including the metabolism of steroid hormones, fatty acids, melatonin, and vitamins
  • CYP1B1 expression has a significant impact on liver sinusoidal endothelial cells (LSEC) angiogenic and inflammatory functions
  • important role for CYP1B1 expression in the regulation of various retinal astrocytes functions, which are important in neurovascular development and integrity
  • mitochondrial CYP1B1 is involved in pregnenolone synthesis in human glial cells
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS development , electron transport , detoxification
    text
  • metabolizes endogenous compounds such as steroid hormones, fatty acids, and xenobiotics, including drugs and carcinogens
  • putative role in ocular development
  • PATHWAY
    metabolism drug
    signaling sensory transduction/vision
    a component
    INTERACTION
    DNA
    RNA
  • CYP1B1 mRNA is strongly and dose dependently induced by TCDD
  • small molecule cofactor, nucleotide,
  • NADPH, heme
  • protein
  • flavoprotein P450 oxidoreductase (POR)
  • modifier of MYOC (role in digenic mechanism of GLC1A)
  • CYP1B1 may play an important role in preventing ubiquitin-proteasome-mediated XIAP degradation through the activation of PRKCE signaling in cancer cells
  • cell & other
    REGULATION
    activated by in retinal ganglion cells during development,
    and overexpression of the gene increased
    survival of the cells
    induced by dioxin
    by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
    Other might be regulated by NR5A1 and CREB1
    ASSOCIATED DISORDERS
    corresponding disease(s) GLC3A , PTA2
    related resource Human Cytochrome P450 (CYP) Allele Nomenclature Committee
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in high-grade PIN and in prostate cancer
    tumoral     --low  
    by hypermethylation in colorectal cancer
    constitutional     --over  
    of CYP1A1 and CYP1B1 in ovarian/peritoneal endometriotic lesions
    tumoral     --over  
    in hormone-related cancers such as breast cancer, ovarian cancer, or prostate cancer compared to other cancers
    tumoral     --over  
    in breast cancer with poor prognosis
    Susceptibility
  • to the development of glaucoma (GLC1N), primary open angle glaucoma (PCG)
  • to endometrial cancer
  • to neonatal-onset (NO) primary congenital glaucoma
  • Variant & Polymorphism SNP , other
  • combination of R368H and Myoc mutation correlates with earlier manifestation of GLC1A
  • polymorphisms on exons 2 and 3 increasing the risk of endometrial cancer
  • rs2567206 (T2805C) significantly associated with PCG (
  • heterozygous missens mutations with absent or reduced relative enzymatic activity could be a risk factor for primary open-angle glaucoma
  • patients with CYP1B1 pathogenic variants had a poorer outcome in primary congenital glaucoma
  • Candidate gene for Peters anomaly
    Marker
  • CYP4Z1 and CYP1B1 have the potential to be biomarkers or targets for novel anticancer therapy for bladder cancer.
  • Therapy target
    SystemTypeDisorderPubmed
    metabolismlipid 
    therapeutic target for the treatment of metabolic diseases
    cancerurinary 
    targets for novel anticancer therapy for bladder cancer
    cancerreproductivebreast
    CYP1B1 inhibitors in combination with chemotherapeutic drugs may provide a novel targeted and effective approach to adjuvant or neoadjuvant therapy against certain forms of highly metastatic breast cancer
    ANIMAL & CELL MODELS
  • Cyp1b1-/- mice have ocular drainage structure abnormalities resembling those reported in human PCG patients. In Cyp1b1-/- mice tyrosinase gene (Tyr) acts as a modifier of the drainage structure phenotype